On 25 June, a release on Mondo Visione advised that the SEC has announced that Novartis AG, a global pharmaceutical and healthcare company headquartered in Switzerland, has agreed to pay over $112 million to settle charges that it violated the books and records and internal accounting controls provisions of the FCPA. The allegations relate to improper payments or to provide benefits to public and private healthcare providers in South Korea, Vietnam, and Greece in exchange for prescribing or using Novartis or Alcon products.
https://mondovisione.com/media-and-resources/news/sec-charges-novartis-ag-with-fcpa-violations/
If you would like to say thanks by making a small contribution, in case I need to upgrade or replace my computers and other paraphernalia, I have a page at https://www.buymeacoffee.com/KoIvM842y